Study in the US during the Omicron wave followed 248 metformin users over 6 months.
Starting metformin within a week of COVID reduced the risk of Long COVID or death by 53%.
Safe and inexpensive with results aligning with earlier data.
Study in the US during the Omicron wave followed 248 metformin users over 6 months.
Starting metformin within a week of COVID reduced the risk of Long COVID or death by 53%.
Safe and inexpensive with results aligning with earlier data.
“Evusheld tx my long COVID
Evusheld is a combo of 2 long-acting monoclonal antibodies Tixagevimab/cilgavimab
in 2021 I got this tx for acute COVID infection ⬇️ Prevented me from becoming hospitalized, I felt better within 45 mins of injection & my long COVID from 2020 resolved” Thread:
“Participants were randomly assigned via 2 × 3 parallel factorial randomisation (1:1:1:1:1:1) to receive metformin plus ivermectin, metformin plus fluvoxamine, metformin plus placebo, ivermectin plus placebo, fluvoxamine plus placebo, or placebo plus placebo.
When metformin was started within 3 days of symptom onset, the HR was 0·37 (95% CI 0·15–0·95). There was no effect on cumulative incidence of long COVID with ivermectin (HR 0·99, 95% CI 0·59–1·64) or fluvoxamine (1·36, 0·78–2·34) compared with placebo.
There was no effect on cumulative incidence of long COVID with ivermectin (HR 0·99, 95% CI 0·59–1·64) or fluvoxamine (1·36, 0·78–2·34) compared with placebo.
…Outpatient treatment with metformin reduced long COVID incidence by about 41%, with an absolute reduction of 4·1%, compared with placebo. Metformin has clinical benefits when used as outpatient treatment for COVID-19 and is globally available, low-cost, and safe.”
(So of course we will probably never get access to this.)
“The goal of this study is to confirm that niclosamide can solve the complex symptoms of Long COVID through multiple mechanisms such as virus suppression, inflammation suppression, and neuroprotection. We hope that the clinical trial will be successful and provide a practical treatment option for Long COVID patients, which will be historic."